News Conference News AHA 2016 ¿Dolor Muscular Secundario a las Estatinas? Según el Análisis GAUSS-3 Podría ser Genético Michael O'Riordan November 22, 2016
News Conference News AHA 2016 Statin-Associated Muscle Pain? It May Be Your Genes, Says GAUSS-3 Analysis Michael O'Riordan November 22, 2016
News Conference News AHA 2016 PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad Michael O'Riordan November 15, 2016
News Daily News New USPSTF Guidelines Recommend Statins in ‘Appropriately Selected’ Primary-Prevention Patients Michael O'Riordan November 13, 2016
News Daily News High-Intensity Statin Therapy Offers Survival Benefit Over Moderate-Intensity Statins in CVD Patients Michael O'Riordan November 10, 2016
News Daily News El Tratamiento con Estatinas de Alta Intensidad Ofrece una Mayor Supervivencia sobre las Estatinas de Intensidad Moderada en Pacientes con Enfermedad Cardiovascular Michael O'Riordan November 10, 2016
News Daily News MILANO-PILOT Falters, Effectively Ending the ApoA-1 Milano Saga Michael O'Riordan November 09, 2016
News Daily News FH Screening Started at Time of Childhood Immunization Feasible and Effective Michael O'Riordan October 28, 2016
News Daily News La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular Michael O'Riordan October 18, 2016
News Daily News AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications Michael O'Riordan October 18, 2016
News Daily News Use of Evidence-Based Medical Therapy Steadily Improving in Acute MI Patients Postdischarge Michael O'Riordan September 30, 2016
News Daily News Según un Extenso Análisis Europeo el Uso Actual de FAINE se asocia a un Mayor Riesgo de Insuficiencia Cardíaca Michael O'Riordan September 30, 2016
News Daily News Current NSAID Use Linked to Increased Risk of Heart Failure, Large European Analysis Shows Michael O'Riordan September 30, 2016
News Daily News Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT Michael O'Riordan September 29, 2016
News Daily News Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies Michael O'Riordan September 27, 2016
News Daily News CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study Michael O'Riordan September 22, 2016